Observational analysis shows EGCG improves cognitive impairment and neural degeneration in high altitude, suggesting neuroprotective properties.
Motivation: The neuroprotective effects of Epigallocatechin-3-gallate (EGCG) on chronic high altitude (HA)-induced nerve damage have not been reported. Goal(s): The purpose of this study is to use quantitative susceptibility mapping (QSM) to dynamically evaluate the status of brain damage and the effect of EGCG at HA. Approach: A model of HA environments-induced brain injury was established for different weeks. Neural ultrastructural changes were evaluated with electron microscope. Salidroside treatment was chosen as the positive control group. Results: The susceptibility values in the hippocampus, ferritin, iron content increased significantly after HA exposure. EGCG attenuated HA environments-induced cognitive impairment, iron accumulation, microglial activation and neural degeneration. Impact: The effects of EGCG in reducing EPO and metal chelating property about iron were dose-dependent, with effects of EGCG being similar to those of salidroside. QSM provides a potential complementary imaging technique to detect the effect of treating HA diseases.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: